BNC Korea Co., Ltd. (256840) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for BNC Korea Co., Ltd. (256840:KRX), powered by AI.

Current Price
₩2,995
P/E Ratio
72.2
Market Cap
204.8B
Sector
Healthcare
What is the BNC Korea Co., Ltd. stock price forecast?

BNC Korea Co., Ltd. is currently trading at ₩2,995. View real-time AI analysis on Alpha Lenz.

What is BNC Korea Co., Ltd. insider trading activity?

View the latest insider trading data for BNC Korea Co., Ltd. on Alpha Lenz.

What is BNC Korea Co., Ltd.'s P/E ratio?

BNC Korea Co., Ltd.'s P/E ratio is 72.2.

BNC Korea Co., Ltd.

KRX · 256840
₩2,995+95(+3.28%)Market closedKRX regular session 09:00–15:30 KST
Ask about BNC Korea Co., Ltd.'s future dividend policy...
Alpha Chat Insight

BNC Korea Co., Ltd. trades at a P/E of 72.2 (premium valuation) with modest ROE of 1.2%. 3Y revenue CAGR of 31.4% highlights clear growth momentum.

Ask for details

Company Overview

BNC Korea Co., Ltd. is a prominent player in the manufacturing and distribution sector, primarily focused on providing high-quality medical supplies and beauty products. The company embodies a strong commitment to innovation and excellence, catering to a diverse range of industries that include healthcare, cosmetics, and personal care. With an emphasis on developing state-of-the-art technological solutions, BNC Korea Co., Ltd. enhances the efficacy and safety of its product offerings. The firm has established a significant presence in the international market, building a reputation for reliability and customer satisfaction. Leveraging advanced research and development facilities, BNC Korea Co., Ltd. continually expands its product lines to address the growing demand for effective and accessible medical products. Its deep understanding of the healthcare industry's needs positions the company as an essential contributor to global wellness and beauty trends. Through strategic partnerships and a robust distribution network, BNC Korea Co., Ltd. ensures that its innovative solutions reach a broad audience, reinforcing its role as a crucial player in the financial markets, particularly in sectors related to health and beauty product manufacturing.

CEO최완규
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees242

Company Statistics

FY 2025

Profile

₩204,842,683,570Market Cap
₩95,899,224,530Revenue
68.39MShares Out
242Employees

Margins

41.06%Gross
16.34%EBITDA
1.81%Operating
4.52%Pre-Tax
2.13%Net

Valuation

72.21P/E
0.88P/B
2.14EV/Sales
8.80EV/EBITDA
-105.22P/FCF

Growth (CAGR)

31.37%Rev 3Yr
37.60%Rev 5Yr
N/AOp Inc 3Yr
12.84%Op Inc 5Yr
N/ANet Inc 3Yr
7.52%Net Inc 5Yr

Returns

0.75%ROA
1.22%ROE
1.82%ROIC

Financial Health

₩99,237,965,070Cash & Cash Equivalents
₩-60,788,384,580Net Debt
16.05%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

BNC Korea Co., Ltd. (ticker: 256840) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 242 employees. Market cap is $204.8B.

The current price is ₩2,995 with a P/E ratio of 72.21x and P/B of 0.88x.

ROE is 1.22% and operating margin is 1.81%. Annual revenue is $95.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
BNC Korea Co., Ltd. (256840) Stock Forecast 2026 ₩2,995 — Price, Financials & Analyst Targets | Alpha Lenz